I think this is a bush-league company that won’t be able to satisfactorily exploit the potential market for DHA/ARA additives in infant formula and foods.
The best option, IMHO, is to sell the business to a larger company. At a low enough price, I might consider buying as a takeover play.
Market Data 
Markets 
AI
